ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Carcinoma
Hypersensitivity
Adenocarcinoma
Recurrence
Castration-Resistant Prostatic Cancer

Prostate Cancer trials near Salt Lake City, UT, USA:

Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...

Active, not recruiting
Prostate Cancer
Drug: Leuprolide Acetate
Drug: Relugolix

Phase 3

Sumitomo Pharma
Sumitomo Pharma

Murray, Utah, United States and 107 other locations

Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-110

Phase 1, Phase 2

Arvinas
Arvinas

Salt Lake City, Utah, United States and 53 other locations

recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...

Enrolling
Neuroendocrine Prostate Cancer
Metastatic Prostate Cancer
Drug: ORIC-944

Phase 1

Oric Pharmaceuticals

Salt Lake City, Utah, United States and 5 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Prednisone
Drug: Placebo

Phase 2, Phase 3

Lilly
Lilly

Salt Lake City, Utah, United States and 111 other locations

This study evaluates the diagnostic performance and safety of \[18F\]PSMA-1007 PET/CT imaging in patients with suspected recurrence of prostate...

Active, not recruiting
Prostate Cancer Recurrent
Prostate Cancer
Drug: [18F]PSMA-1007

Phase 3

ABX Advanced Biochemical Compounds

Salt Lake City, Utah, United States and 5 other locations

This is an open-label, phase II umbrella trial assessing the anti-tumor activity of enfortumab alone and in combination with other anti-cancer...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Enfortumab vedotin

Phase 2

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

Enrolling
Prostatic Neoplasms
Prostate Cancer
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Murray, Utah, United States and 6 other locations

This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate ca...

Active, not recruiting
Prostate Cancer Metastatic Castration-Resistant
Stage IV Prostate Cancer
Drug: Abiraterone Acetate
Drug: Prednisone

Phase 2

Northwestern University
Northwestern University

Salt Lake City, Utah, United States and 17 other locations

be prolonged in participants with metastatic castration-resistant prostate cancer (MCRPC) who receive lorigerlimab in addition to t...

Enrolling
Prostate Cancer Recurrent
Androgen-Resistant Prostatic Cancer
Drug: docetaxel
Drug: Prednisone

Phase 2

MacroGenics
MacroGenics

West Valley City, Utah, United States of America and 50 other locations

of LAVA-1207 alone or with low dose interleukin-2 or Pembrolizumab, in patients with therapy refractory metastatic castration resistant prostate...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Biological: LAVA-1207
Biological: LAVA-1207 plus Pembrolizumab

Phase 1, Phase 2

Lava Therapeutics

Salt Lake City, Utah, United States and 8 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems